Share This Page

Alzheimer's And Dementia Weekly

Support & Insight for the Autumn of Life

Have an account?

Drugs:Dementia

Two women looking at a computer screen with mri images on it

Leqembi’s Real Advantage Isn’t the Drug — It’s the Network

March 17, 2026 No Comments

The diagnostic and treatment network behind Leqembi may be its biggest competitive edge.

Common Alzheimer’s Medications Slow Cognitive Decline

March 6, 2026 No Comments

Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to five years after an Alzheimer’s diagnosis. One medication significantly reduced the risk of developing severe dementia.

Why Leqembi Works: Fc Activates the Brain’s Cleanup Crew

March 1, 2026 No Comments

New research reveals that Leqembi’s Fc region switches on microglia — the brain’s immune cells — helping them clear toxic amyloid. Here’s why that mechanism matters for treatment and safety.

Senior couple smiling and enjoying each other's company indoors.

Korsana’s Alzheimer’s Treatment Promises Safer Care — But When?

February 20, 2026 No Comments

A safer Alzheimer’s treatment may be on the horizon — but families still have meaningful choices today.

Doctor shows patient brain scans on tablet

How Doctors Decide Who Qualifies for Leqembi

February 19, 2026 No Comments

Many diagnosed patients won’t qualify — here are the
7 medical criteria.

ai generated, neuron, brain, synapses, biology, science, thinking, cell, anatomy, nerves, neural, mind, dendrites, connection, physiology, neurology

How Lecanemab Clears Amyloid and Slows Alzheimer’s—even as Tau Spreads

February 5, 2026 1 Comment

New early-onset Alzheimer’s data show that lecanemab can slow functional decline—even while tau continues to spread in the brain. The research helps explain how amyloid-lowering treatments may still preserve daily life, despite the disease’s complexity.

What 400 Alzheimer’s Patients Gained From Leqembi and Kisunla

January 29, 2026 No Comments

In a one-hour seminar, a leading neurologist answers the most important questions families ask about what these new therapies can realistically deliver — from effectiveness and safety to eligibility, infusion logistics, cost, and access.

Happy senior couple walking outdoors, holding colorful flowers. A delightful moment capturing love and togetherness.

Leqembi Likes Asia’s Genes. Why?

December 30, 2025 No Comments

New evidence suggests genetics—not geography—may explain why Leqembi causes fewer ARIA brain side effects in parts of Asia, and what that means for families everywhere.

"Alzheimer's Treatment Demand" chart behind patient, caregiver and doctor.

Leqembi Prescriptions Could Rise Sharply. Why?

December 21, 2025 No Comments

Alzheimer’s treatment eligibility may be far larger than previously thought. A major Nature study using blood tests suggests millions more older adults could qualify for treatment than current use reflects. As diagnosis becomes easier, demand for drugs like Leqembi could shift sharply.

Exelon (Rivastigmine Transdermal Patch for Alzheimer's)

Rivastigmine Alzheimer’s Patch: New Research, Better Comfort

December 11, 2025 No Comments

New studies highlight smoother tolerability, easier routines, and practical safety updates that make the rivastigmine patch an increasingly caregiver-friendly option.

Designing Rooms for Dementia

September 3, 2026

FREE 32-PAGE BOOK: Dementia design improves the independence of people with dementia. This online book is available at no charge. Learn dozens of clever design tips that can make a world of difference.

Sweet Food, Bitter Pills & Dementia

September 3, 2026

DEMENTIA DIET TIPS – VIDEO: What’s tasty and what’s not for people with Alzheimer’s? Find out from Teepa Snow. Learn what to expect when medication is mixed with food. Turn meals into a real time for connecting.

Move More! No Exercise for 10 Days Decreases Brain Blood Flow

September 2, 2026

Everyone knows we should exercise. But it’s hard. Sometimes realizing the consequences of not exercising can get us moving. Here’s a bit of really motivating research.

Most Popular Stories

85 with Dementia? Good Chance It’s HS-AGING, Not Alzheimer’s

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?

Grandmother in black and white striped shirt hugging girl in black and white striped shirt

A Grandchild for One Day Keeps Dementia Away

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?

“I’ve Got You Under My Skin,” By Dad with Dementia & Son

Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!

Is Alzheimer’s Catchy?

It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.